InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by RUDNICK SETH, Director. Officer active across 2 companies, notably G1 Therapeutics, Inc.. Cumulatively, 5 filings have been recorded. History available since 17 June 2021. The latest transaction was filed on 29 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
7,969 shares@ US$0.3950.0% of flowCommon StockSEC:0001562180-21-004586
7,969 shares@ US$0.3950.0% of flowCommon StockSEC:0001562180-21-004586:0
4,389 shares0Common StockSEC:0001562180-21-004395
4,389 shares0Common StockSEC:0001562180-21-004395:0
47,501 sharesCommon SharesSEC:0001104659-16-095176:0
5 of 5 declarations
About RUDNICK SETH
Seth Rudnick is a Director at G1 Therapeutics, Inc. In this role, he contributes to the governance of the company and the strategic direction of its operations. G1 Therapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer. Seth brings significant expertise in the field, supporting the company's efforts to improve patient outcomes.
